Manipal Hospital IPO: IPO Date, Price Band, GMP & Allotment Status

Manipal Hospital IPO, formally listed as Manipal Health Enterprises Limited, filed its Draft Red Herring Prospectus (DRHP) with SEBI on March 23, 2026. The issue comprises a Fresh Issue of ₹8,000 crore and an Offer for Sale (OFS) of up to 4,32,27,668 equity shares, proposed for listing on both BSE and NSE.

Manipal Health Enterprises is India's largest multispecialty hospital group by bed capacity, operating 38 hospitals with 10,761 licensed beds as of September 30, 2025, and 48 hospitals with 12,367 beds on a proforma basis including recent acquisitions. The company reported total income of ₹9,409 crore in FY25 with an EBITDA margin of 26.65%.

This blog covers the complete picture for the Manipal Hospital IPO 2026, DRHP highlights, financial data, issue structure, use of proceeds, price band expectations, GMP, allotment process, and how to apply.

---

---

1. Manipal Hospital IPO Dates 2026

The Manipal Hospital IPO date has not been officially announced. The DRHP was filed with SEBI on March 23, 2026. After SEBI's standard review period of 30–75 days, the IPO dates will be confirmed in the final RHP.

Set a date alert on the IPOwiz app to get notified the moment the Manipal Hospital IPO open date is officially confirmed.

2. Manipal IPO Issue Size: Fresh Issue and OFS

The Manipal Hospital IPO is a combined Fresh Issue and Offer for Sale structure:

The OFS component means a portion of the funds raised will go to existing shareholders who are partially exiting their positions. The Fresh Issue proceeds of ₹8,000 crore will be used for specific company purposes as detailed in Section 9.

3. Manipal Hospital IPO Price Band and Lot Size

The Manipal Hospital IPO price band and lot size have not been announced at this stage. Both will be confirmed in the final RHP filed before the subscription window opens. Given the ₹8,000 crore fresh issue size and the company's scale, this is expected to be one of the larger mainboard IPOs of 2026.

For mainboard IPOs, the standard minimum retail lot is typically designed to keep the minimum investment in the ₹13,000–₹15,000 range. The exact lot size will depend on the final price band.

This page will be updated with the confirmed Manipal Hospital IPO price band and lot size as soon as they are officially declared. Set a price band alert on the IPOwiz app to get notified instantly.

4. About Manipal Health Enterprises Limited

Manipal Health Enterprises Limited is the parent entity behind the Manipal Hospitals brand, part of the Manipal Group founded by T. M. A. Pai. The company operates a network of multi-specialty hospitals, clinics, and diagnostic centres across India, offering tertiary and quaternary healthcare services.

The company's service portfolio covers oncology, cardiology, neurology, orthopaedics, organ transplants, and preventive healthcare. Its hospitals are positioned in both metro and non-metro markets, with a stated focus on clinical quality and operational efficiency.

The promoters of the company are Dr. Ranjan Ramdas Pai, Manipal Global Health Services, MEMG International Ltd, Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd., holding a combined pre-IPO stake of 81.42%.

5. Hospital Network: Scale and Presence

Manipal Health Enterprises operates one of the largest private hospital networks in India. Key network metrics as of September 30, 2025:

The company has a stated leadership position in three metro markets, Bengaluru, Kolkata, and Pune, alongside a presence in non-metro hospital markets. This geographic distribution across metros and non-metros is a differentiator compared to hospital chains with concentrated single-city presence.

6. Competitive Strengths From the DRHP

Manipal Health Enterprises highlights the following strengths in its DRHP filing:

• India's largest multispecialty hospital group by bed capacity: 12,367 licensed beds on a proforma basis, with pan-India presence
• Leadership in three metros: The only private hospital chain with market leadership in Bengaluru, Kolkata, and Pune simultaneously
• Balanced metro and non-metro presence: Reduces geographic revenue concentration compared to single-city hospital networks
• Established brand recognition: The Manipal Hospitals brand is recognized among patients, doctors, and healthcare professionals across its operating markets
• Advanced medical infrastructure: Hospitals equipped with technology for complex procedures including organ transplants, oncology, and quaternary care
• Track record of profitable growth: Consistent revenue and EBITDA growth from FY23 to FY25, with EBITDA margins improving from 24.9% to 26.65%
• Digital health and acquisition strategy: Active expansion through acquisitions and digital health investments, reflected in the proforma bed count increase from 10,761 to 12,367

7. Manipal Hospital IPO Financials: Revenue, PAT and EBITDA

The following financial data is sourced from the DRHP filing (proforma consolidated figures):

Key observations from the financials:

• Total income grew from ₹4,927 crore in FY23 to ₹9,409 crore in FY25, a near-doubling in two years, reflecting both organic growth and acquisitions
• EBITDA grew from ₹1,228 crore to ₹2,455 crore over the same period, with margins improving consistently
• PAT remained relatively flat between FY24 (₹533 crore) and FY25 (₹534 crore) despite revenue growth, indicating higher depreciation and interest costs from recent acquisitions and debt, which the IPO proceeds are partially intended to address
• Total assets nearly doubled from FY24 to FY25, reflecting the consolidation of acquired hospital assets

8. Key Performance Indicators (KPIs)

*H1 FY26 RoNW is on a half-year basis and not directly comparable to the full-year FY25 figure.

The improving EBITDA margin from 26.65% in FY25 to 27.99% in H1 FY26 indicates continued operating leverage as the hospital network scales. A ROCE of 26.98% is strong for a capital-intensive healthcare business, reflecting efficient utilization of the deployed capital base.

9. Use of IPO Proceeds

The ₹8,000 crore Fresh Issue proceeds will be used for three specific purposes as disclosed in the DRHP:

Key point for investors: ₹5,378 crore, approximately 67% of the fresh issue, is earmarked for debt repayment at the subsidiary level. This is a direct path to reducing the company's interest expense, which has been a key factor keeping PAT growth below revenue and EBITDA growth. Post-IPO, a lower debt burden should improve net profit margins going forward.

10. Investor Category Reservation

Standard SEBI mainboard allocation norms apply. The 35% retail quota on a large issue like this means a significant absolute number of shares will be available for retail applicants, though high oversubscription, which is expected for a brand of this scale, will reduce individual allotment probability.

11. IPO Lead Managers and Registrar

The Manipal Hospital IPO is being managed by one of the largest investment bank syndicates seen in an Indian healthcare IPO:

The involvement of seven investment banks, including Goldman Sachs, JP Morgan, Jefferies, and UBS, indicates strong international institutional interest in this IPO. Global bank participation in Indian hospital IPOs is a signal of significant foreign institutional investor (FII) demand being anticipated.

12. Peer Comparison: Manipal Hospital IPO vs Listed Hospital Stocks

Manipal Health Enterprises will enter a segment that already includes several listed private hospital groups. Here is how the key metrics compare based on publicly available data:

*Peer figures are approximate based on publicly available FY24–25 annual data. Manipal figures are from DRHP proforma financials.

Key observation: Manipal's EBITDA margin of 26.65% is competitive with Max Healthcare and KIMS, both of which trade at premium valuations on listed markets. Manipal's revenue scale at ₹9,409 crore positions it as the second-largest private hospital group in India by revenue after Apollo Hospitals. The final valuation multiple will be a key factor for investors to assess once the price band is declared.

13. Key Risks to Evaluate

Before applying for the Manipal Hospital IPO, investors should review the following risk factors:

• High debt at subsidiary level: ₹5,378 crore of the IPO proceeds are directed at repaying borrowings at Manipal Hospitals Private Limited, indicating significant pre-IPO leverage at the operating subsidiary level
• Flat PAT growth despite revenue growth: PAT was ₹533 crore in FY24 and ₹534 crore in FY25, essentially flat, even as revenue grew significantly. This is primarily due to higher interest and depreciation costs from acquisitions. Post-IPO debt reduction should improve this, but investors should monitor net margins closely
• Acquisition integration risk: The proforma bed count of 12,367 (vs reported 10,761) reflects recent acquisitions that are still being integrated. Execution risk in integrating newly acquired hospitals is a relevant consideration
• Healthcare sector regulatory risk: Price capping on medical devices, drugs, and procedures by government authorities can affect revenue per procedure and overall hospital profitability
• Doctor retention risk: The quality and reputation of a hospital network is significantly dependent on the medical professionals it employs. Doctor attrition or movement to competing networks is a business risk specific to the healthcare sector
• Promoter OFS component: The OFS of 4.32 crore shares means a portion of IPO proceeds goes to selling shareholders, investors should review which promoter entities are selling and in what proportion in the final RHP
• Valuation at listing: Given the large issue size and high-profile nature of the IPO, valuations may be set at a premium. Investors should compare the price band to peer P/E and EV/EBITDA multiples once announced

14. Manipal Hospital IPO GMP Today (Grey Market Premium)

The Manipal Hospital IPO GMP is not available at this stage, as the DRHP was filed on March 23, 2026 and the price band has not yet been announced. Grey market activity for mainboard IPOs of this scale typically begins building 2–3 weeks before the subscription window opens, and increases significantly once the price band is officially declared.

For the latest Manipal Hospital IPO GMP today, check the live tracker on the IPOwiz app, updated daily once grey market activity begins. GMP is an unofficial indicator and is not regulated by SEBI. It should be considered alongside the company's fundamentals, not as a standalone decision factor.

15. Manipal Hospital IPO Allotment Status: How to Check

The Manipal Hospital IPO allotment status date will be confirmed once the subscription window dates are officially announced. Allotment results are typically declared 6 days after the IPO close date for mainboard issues.

To check your Manipal Health Enterprises IPO allotment status once results are declared:

• KFin Technologies website: The official registrar, visit kfintech.com or use the dedicated IPO allotment portal and enter your PAN or application number. Contact: 040-6716-2222 | manipal.ipo@kfintech.com
• IPOwiz app: Use the Bulk PAN Import feature to check allotment status for all family members in one step, no need to enter each PAN separately on the registrar site

Download here: Download IPOwiz, Bulk PAN Allotment Tracker

16. How to Apply for Manipal Hospital IPO

Once the subscription window opens (dates to be announced), here is the step-by-step process:

1. Log into your broker app (Zerodha, Angel One, Groww, or any SEBI-registered broker).
2. Go to the IPO section and search for Manipal Health Enterprises Limited.
3. Select the number of lots. Choose Cut-off Price for the highest allotment probability in the retail category.
4. Approve the UPI mandate via BHIM or your bank's UPI app within the required window. Funds are blocked, not debited, until allotment is confirmed.
5. Track live Manipal Hospital IPO subscription status on the IPOwiz app throughout the subscription window.
6. Check your Manipal Hospital IPO allotment status on the IPOwiz app or KFin Technologies website once results are declared.

Note: Given the large issue size and high retail interest expected, applying on Day 1 or Day 2 of the subscription window is recommended to avoid last-minute UPI technical delays.

---

Manipal Hospital IPO Quick Facts

---

Conclusion

The Manipal Hospital IPO 2026 is one of the most significant healthcare sector listings in India in recent years. With a ₹8,000 crore fresh issue, 48 hospitals and 12,367 beds on a proforma basis, and FY25 revenue of ₹9,409 crore at a 26.65% EBITDA margin, Manipal Health Enterprises brings substantial operational scale and financial data for investors to evaluate.

The key variables to monitor as the IPO progresses are the official IPO date announcement, price band, final valuation multiple relative to listed peers, and the post-IPO debt profile following the planned ₹5,378 crore debt repayment. All updates, including the Manipal Hospital IPO GMP, subscription status, and allotment status, will be tracked in real time on the IPOwiz app.

---

Frequently Asked Questions (FAQ)